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Abstract
The product subject of this assessment is L-valine produced by fermentation with a strain of
Corynebacterium glutamicum (CGMCC 11675). It is intended to be used in feed and water for drinking for
all animal species and categories. Owing to the uncertainties regarding the possible genetic modiﬁcation
of the original production strain, the FEEDAP Panel cannot conclude on the safety of the additive L-valine
produced with C. glutamicum CGMCC 11675 for the target species, the consumers, the users and the
environment. The FEEDAP Panel has concerns on the safety for the target animals of the simultaneous
oral administration of valine-containing additives via feed and water for drinking. In the absence of data,
the FEEDAP Panel cannot conclude on the potential of L-valine produced with C. glutamicum CGMCC
11675 to be toxic by inhalation, irritant to skin or eyes, or on its potential to be a dermal sensitiser. The
product is considered an efﬁcacious source of the amino acid L-valine for all animal species. The
supplemental L-valine requires protection against rumen degradations in order to be as efﬁcacious in
ruminant as in non-ruminant species.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Agri Nutrition BV2 for authorisation of the product
L-valine (≥98.5%) produced by fermentation using Corynebacterium glutamicum CGMCC 11675, when
used as a feed additive for all animal species (category: nutritional additive; functional group: amino
acids, their salts and analogues).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). The particulars and documents in
support of the application were considered valid by EFSA as of 16 August 2016.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product L-valine (≥98.5%) produced by fermentation using C. glutamicum CGMCC 11675 for all animal
species, when used under the proposed conditions of use (see Section 3.1.4).
1.2. Additional information
L-Valine (minimum 98.5%) produced by fermentation using C. glutamicum CGMCC 11675 for all
animal species is the object of the present assessment. It is proposed as nutritional feed additive,
(functional group: amino acids, their salts and analogues) to feed and water for drinking in all animal
species and categories. The product under assessment, L-valine (minimum 98.5%) produced by
fermentation using C. glutamicum CGMCC 11675, has not been previously authorised in the European
Union (EU).
The Scientiﬁc Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) issued 6
opinions (EFSA 2008a,b; EFSA FEEDAP Panel, 2013, 2014a, 2015a,b, 2019) on the safety and efﬁcacy of
L-valine produced by fermentation using different strains of Escherichia coli or C. glutamicum as a
nutritional additive. The safety of L-valine when used as food ﬂavouring was assessed by Joint FAO/WHO
Expert Committee on Food Additives (JECFA; WHO, 2006), by the EFSA Panel on Food Additives,
Flavourings, Processing Aids and Materials in contact with Food (AFC) (EFSA, 2008c) and by the FEEDAP
Panel (EFSA FEEDAP Panel, 2014b) when used as feed ﬂavouring for animal nutrition. The FEEDAP
Panel issued one opinion on the safety and efﬁcacy of the use of amino acids (chemical group 34) when
used as ﬂavourings for all animal species (EFSA FEEDAP Panel, 2014b).
L-Valine produced by C. glutamicum strains KCCM 80058 or DSM 25202 and L-valine produced by
E. coli strains NITE SD 00066 or NITE BP-01755 is currently authorised as a nutritional additive for all
animal species without restrictions by Commission Implementing Regulation (EU) 848/20143, Commission
Implementing Regulation (EU) 1236/20144 and Commission Implementing Regulation (EU) 1114/20155.
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Agri Nutrition BV, Hanzestraat 1, 7006 RH, Doetinchen. The Netherlands. Representing Xinjiang Fufeng Biotechnologies Co., Ltd.
3 Commission Implementing Regulation (EU) No 848/2014 of 4 August 2014 concerning the authorisation of L-valine produced
by Corynebacterium glutamicum as a feed additive for all animal species and amending Regulation (EC) No 403/2009 as
regards the labelling of the feed additive L-valine. OJ L 232, 5.8.2014, p. 13.
4 Commission Implementing Regulation (EU) No 1236/2014 of 18 November 2014 concerning the authorisation of L-valine
produced by Corynebacterium glutamicum (DSM 25202) as a feed additive for all animal species Text with EEA relevance OJ L
332, 19.11.2014, p. 26.
5 Commission Implementing Regulation (EU) 2015/1114 of 9 July 2015 concerning the authorisation of L-valine produced by
Escherichia coli as a feed additive for all animal species and amending Regulation (EC) No 403/2009 and Implementing
Regulations (EU) No 848/2014 and (EU) No 1236/2014 (Text with EEA relevance) OJ L 182, 10.7.2015, p. 18.
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L-Valine produced by chemical synthesis or product hydrolysis is authorised for use in feed as ﬂavouring
(EU Flavour Information System (FLAVIS) Number [17.028]) by Commission Implementing Regulation
(EU) 2018/2496.
L-Valine is authorised for use in food,7,8 cosmetics9 and as a veterinary medicinal product.10 L-Valine
[17.028] is currently listed in the EU database of ﬂavouring substances11 and is authorised for use in
food as ﬂavouring.
L-Valine has a dedicated monograph in the European Pharmacopoeia.12
The Panel on nutrition, dietetic products, novel food and allergy of the Norwegian Scientiﬁc
Committee for Food Safety (VKM, 2016) published an opinion on the safety of L-valine in food
supplements at 1,500, 1,750, 2,000, 2,250 and 2,500 mg/kg per day for the general population (ages
10 years and above) risk assessment of ‘other substances’ – L-leucine, L-isoleucine and L-valine, the
branched chain amino acids.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier13 in support of the authorisation request for the use of L-valine (minimum 98.5%) produced by
C. glutamicum CGMCC 11675 as a feed additive for all animal species.
The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA or other expert bodies, peer-reviewed scientiﬁc papers and
other scientiﬁc reports to deliver the present output.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the L-valine produced by C. glutamicum CGMCC 11675 in animal feed.
The Executive Summary of the EURL report can be found in Annex A.14
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of L-valine (minimum
98.5%) produced by C. glutamicum CGMCC 11675 is in line with the principles laid down in Regulation
(EC) No 429/200815 and the relevant guidance documents: Technical Guidance for assessing the safety of
feed additives for the environment (EFSA, 2008d), Technical Guidance: Microbial Studies (EFSA, 2008e),
Guidance on nutritional additives (EFSA FEEDAP Panel, 2012a), Guidance on the assessment of bacterial
susceptibility to antimicrobials of human and veterinary importance (EFSA FEEDAP Panel, 2012b),
Guidance for establishing the safety of additives for the consumer (EFSA FEEDAP Panel, 2012c), Guidance
on studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012d)
and Guidance on the characterisation of microorganisms used as feed additives or as production
organisms (EFSA FEEDAP Panel, 2018).
6 Commission Implementing Regulation (EU) 2018/249 of 15 February 2018 concerning the authorisation of taurine, beta-
alanine, L-alanine, L-arginine, L-aspartic acid, L-histidine, D,L-isoleucine, L-leucine, L-phenylalanine, L-proline, D,L-serine, L-tyrosine,
L-methionine, L-valine, L-cysteine, glycine, monosodium glutamate and L-glutamic acid as feed additives for all animal species
and L-cysteine hydrochloride monohydrate for all species except cats and dogs OJ L 53, 23.2.2018, p. 134.
7 Commission Regulation (EC) No 1243/2008 of 12 December 2008 amending Annexes III and VI to Directive 2006/141/EC as
regards compositional requirements for certain infant formulae. OJ L 335 25, 13.12.2008, p. 18.
8 Commission Regulation (EC) No 953/2009 of 13 October 2009 on substances that may be added for speciﬁc nutritional
purposes in foods for particular nutritional uses. OJ L 269 9, 14.10.2009, 11 pp.
9 Commission Decision of 9 February 2006 amending Decision 96/335/EC establishing an inventory and a common
nomenclature of ingredients employed in cosmetic products. OJ L 97, 5.4.2006, pp. 1–528.
10 Commission Regulation (EC) No 1931/1999, amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying
down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs
of animal origin. OJ L 240, 10.9.1999, pp. 3–10.
11 Commission Implementing Regulation (EU) No 872/2012 of 1 October 2012 adopting the list of ﬂavouring substances provided
for by Regulation (EC) No 2232/96 of the European Parliament and of the Council, introducing it in Annex I to Regulation (EC)
No 1334/2008 of the European Parliament and of the Council and repealing Commission Regulation (EC) No 1565/2000 and
Commission Decision 1999/217/EC. OJ L 267, 2.10.2012, p. 1.
12 European Pharmacopoeia monograph 01/2008: 0796, correction 6.0.
13 FEED dossier reference: FAD-2016-0031.
14 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/ﬁnrep-fad-2016-0031_valine.pdf
15 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
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3. Assessment
L-Valine (minimum 98.5%) produced by fermentation using C. glutamicum CGMCC 11675 for all
animal species is the object of the present assessment. It is proposed as nutritional feed additive,
functional group: amino acids, their salts and analogues.
3.1. Characterisation
3.1.1. Characterisation of the production organism
L-Valine is produced by a strain of C. glutamicum which is deposited in the Chinese General
Microbiological Culture Collection Centre (CGMCC) with deposition number CGMCC 11675.16 The
applicant initially stated that the production strain was genetically modiﬁed without providing any
information on the genetic modiﬁcation. When details on the genetic modiﬁcation process were
requested, the applicant sent a statement saying that the strain has not been genetically modiﬁed, with
no details regarding the origin, techniques used and the steps followed to select/obtain the strain.17
The production strain was identiﬁed as belonging to species C. glutamicum by bacterial 16S rRNA
gene sequencing and by its morphological and physiological characteristics.18
Analytical evidence was provided on the susceptibility of the production strain to the antimicrobials
listed in the Guidance on the characterisation of microorganisms used as feed additives or as
production organisms. None of the
minimum inhibitory concentrations exceeded the cut-off values established in the guidance (EFSA
FEEDAP Panel, 2018).
3.1.2. Manufacturing process
The applicant stated that no antibiotics are used during the production process.22
3.1.3. Characterisation of the additive
L-Valine (International Union of Pure and Applied Chemistry (IUPAC)) name: (2S)-2-amino-3-
methylbutanoic acid; synonyms: a-aminoisovaleric acid, 2-amino-3-methylbutyric acid), a compound
identiﬁed by Chemical Abstracts Service (CAS) No 72-18-4 and European Inventory of Existing
Commercial Chemical Substances (EINECS) No 200-773-6, has a molecular weight of 117.15 g/mol;
the molecular formula is C5H11NO2 and its structural formula is given in Figure 1.
Figure 1: Molecular structure of L-valine
16 Technical dossier/Section II/Annex 2.2.1.2a.
17 Technical dossier/Supplementary information July 2017/Annex 8 and supplementary information April 2018/Annex Q1.
18 Technical dossier/Section II/Annex 2.2.1.2b.
22 Technical dossier/Section II/Annex 2.3g.
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The additive is speciﬁed to contain ≥ 98.5% L-valine ‘as is’, < 0.3% moisture and an undetermined
fraction of other amino acids.23 Compliance with the speciﬁcation was conﬁrmed in four batches. Valine
content was 100% on a dry matter basis in all four batches, only traces of moisture (0.1%) were
detected.24
The speciﬁc optical rotation (European Pharmacopoeia method) measured in eight batches ranged
from +27.9 to +28.7° and thus within the range set in the European Pharmacopoeia for the L-
enantiomer of valine (+25.6 to +29.0°).25
Impurities
Three batches of the ﬁnal product were analysed for heavy metals and arsenic. In all cases,
cadmium was 0.001 mg/kg, lead ranged from 0.005 to 0.09 mg/kg, mercury from 0.002 to 0.07 mg/kg
and arsenic was < 0.2 mg/kg in all cases. The microbial contamination was studied in three batches of
the additive: total plate count ranged from 20 to 220 colony forming units (CFU)/g, yeasts and moulds
had 20 CFU/g in all cases, Salmonella spp. was not detected in 10 g samples, E. coli and
Staphylococcus aureus were not detected in 1 g samples.26 As regards mycotoxin concentrations (three
batches analysed), aﬂatoxin B1 was < 1.7 lg/kg, ochratoxin A < 5 lg/kg, zearalenone < 17 lg/kg,
fumonisin < 25 lg/kg and deoxinivalenol < 134 lg/kg. Citrinin ranged from < 15 to 76 lg/kg.27
Polychlorinated dibenzodioxins/dibenzofurans (PCDD/F) and dioxin-like polychlorinated biphenyls (DL-
PCBs) were measured in three batches of the additive. The sum of PCDD/F and DL-PCBs ranged from
0.059 to 0.099 WHO-toxic equivalent (TEQ) pg/g (upper bound) based on 88% dry matter.28 These
impurities do not represent a safety concern.
The antimicrobial activity of one batch of the additive was tested against the reference strains
proposed in the Guidance of microbial studies (EFSA, 2008d). In all cases, the minimum inhibitory
concentration was > 2,500 mg/L which would correspond to a concentration in feed of 0.25%.29 No
antimicrobial activity was detected.
Bacterial endotoxin activities were measured (Limulus amebocyte lysate chromogenic endotoxin
quantitation kit) in three batches of the additive and ranged from 0.006 to 0.034 IU/mg.30
3.1.3.1. Physico-chemical characteristics
The additive is a white crystalline powder. The pH value measured in eight batches of the additive
(1% solution at 21°C) ranged from 5.7 to 6.2.32 The density is 0.5 kg/L.33
The particle size distribution of the additive (three batches) was analysed by laser diffraction.34 The
fractions of particles having diameters < 100, < 50 and < 10 lm diameter ranged 74–79% (v/v), 55–61%
(v/v) and 24–29% (v/v), respectively. The dusting potential analysed in three batches (Stauber–Heubach)
ranged from 11 to 17 g/m3.35
3.1.3.2. Stability and homogeneity
The shelf life of three batches of the additive was studied under two different temperatures (25
and 40°C) when stored in sealed plastic bags protected from light for 3 months. Only one of the three
batches showed losses: 0.5% at 25°C and 0.7% at 40°C.36
23 Technical dossier/Section 2.1.3.
24 Method assessed by the EURL (email exchange).
25 Technical dossier/Section II/Annexes 2.1.3a and 2.1.4b.
26 Technical dossier/Section II/Annex 2.1.4b.
27 Technical dossier/Section II/Annex 2.1.4a.
28 Technical dossier/Supplementary information July 2017/Annex 5.
29 Technical dossier/Section II/Annex 2.2.2.2.
30 Technical dossier/Section II/Annex 2.1.4d.
32 Technical dossier/Section II/Annex 2.1.3a and 2.1.4b; Supplementary information July 2017/Answer to question 6.
33 Technical dossier/Section II/Table 2.1.5a.
34 Technical dossier/Section II/Annexes 2.1.5a, b and c.
35 Technical dossier/Section II/Annexes 2.4.3a, b and c.
36 Technical dossier/Section II.2.4.1/Annex 2.1.4a and Supplementary information July 2017/Answers Sin 161014 ﬁnal.
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The additive (three batches) was incorporated at 10% into a vitamin/mineral premixture also
containing choline chloride.37 The premixtures were stored at room temperature in closed plastic bags
protected from light for 6 months. Only one batch showed a loss of 1%.
The additive under assessment (three batches) was added at a level of 0.5% to a complete mash
feed based on barley, soybean meal and wheat.38 The mash feed was conditioned at 45°C and the
pelleting was done at 65°C. The pelleting process caused a loss of valine of 8% and 10% in two of the
batches tested. Samples of mash and pelleted feed were subsequently stored (packaging and
temperature unknown) for 3 months. Losses of 7% were observed in meal (2 batches) whereas no
losses were observed in pelleted feed.
The homogeneous distribution of one batch of the additive when supplemented at 0.5% inclusion
level in mash pelleted feed was studied by analysing 10 subsamples.39 The coefﬁcient of variation of
the mean was 1.3%.
The stability of the additive (three batches) was studied when diluted to a concentration of 1% in
water for drinking and solutions were stored at room temperature for 24 h.40 A loss of 4% valine was
observed in one batch.
3.1.4. Conditions of use
The additive is intended to be used for all animal species and categories with no minimum or
maximum content speciﬁed. It is intended to be added to feedingstuffs via premixtures or directly into
complete feed and complementary feed. The additive is also proposed for the use in water for
drinking. No inclusion levels are proposed, as the requirements in quantitative terms depend on the
species, the physiological state of the animal, the performance level, the environmental conditions and
the amino acid composition of the unsupplemented diet. No withdrawal period is proposed.
3.2. Safety
Corynebacterium glutamicum is regarded as qualiﬁed presumption of safety (QPS) only when used as
a production organism (EFSA, 2007; EFSA BIOHAZ Panel, 2019). The identity of the production strain has
been established as C. glutamicum and the absence of antimicrobial resistance has been proven.
Therefore, the strain qualiﬁes for the QPS approach for safety assessment. However, uncertainty remains
regarding the possible genetic modiﬁcation of the strain and, therefore, the eventual presence of
recombinant DNA in the additive. In the absence of such information/evidence, it is not possible to assess
the origin and concerns of the sequences that might have been introduced in the strain.
The use of the amino acid ‘per se’ will not raise safety concerns for the target animals provided it is
supplemented in appropriate amounts to the diets. However, due to the risk of nutritional imbalances
and hygienic reasons, associated to the use of amino acids via water for drinking (EFSA FEEDAP Panel,
2010), the FEEDAP Panel has concerns on the safety of the simultaneous oral administration of valine-
containing additives via feed and water for drinking.
The amino acid L-valine, supplemented to feed, will be incorporated into proteins of tissues and/or
products of animal origin and any potential excess will be metabolised and excreted as urea/uric acid
and carbon dioxide. Therefore, the composition of tissues and products of animal origin will not be
affected by the use of L-valine in animal nutrition.
The amino acid L-valine is a physiological and natural component of animals and plants. It is not
excreted as such (but as urea/uric acid and carbon dioxide). The use of L-valine in animal nutrition would
not lead to any localised increase in the concentration of L-valine or its metabolites in the environment.
The additive is highly puriﬁed and is produced by fermentation using a strain which qualiﬁes for the
QPS approach for safety assessment. Uncertainty remains regarding the possible genetic modiﬁcation
of the strain and, therefore, the eventual presence of recombinant DNA in the additive. In the absence
of such information/evidence, it is not possible to assess the origin and concerns of the sequences that
might have been introduced in the strain. The FEEDAP Panel cannot conclude on the safety of the
additive L-valine produced by C. glutamicum CGMCC 11675 for the target species, consumer and the
environment.
37 Technical dossier/Section II.2.4.1/Annexes 2.1.4a and 2.4.1; Supplementary information July 2017/Annex 11 92209 and
Answers SIn 161014 ﬁnal.
38 Technical dossier/Section II.2.4.1/Annexes 2.1.4a and Annex 2.4.1; Supplementary information July 2017/Answers SIn 161014
ﬁnal. feed composition.
39 Technical dossier/Section II.2.4.2/Annex 2.1.4a.
40 Technical dossier/Section II.2.4.1/Annex 2.1.4a.
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3.2.1. Safety for the user
The additive under assessment is a ﬁne powder with a high dusting potential (up to 17 g/m3).
Therefore, inhalation exposure of users is likely.
No studies were submitted to support the safety of the product for user/workers. In the absence of
data, the FEEDAP Panel cannot conclude on the potential of the L-valine to be toxic by inhalation, irritant
to skin or eyes, or on its potential to be a dermal sensitiser. Furthermore, owing to the uncertainties
regarding the possible genetic modiﬁcation of the original production strain, the FEEDAP Panel cannot
conclude on the safety of the additive L-valine produced by C. glutamicum CGMCC 11675 for the users.
3.3. Efﬁcacy
Efﬁcacy studies are not required for amino acids that occur naturally in plant and animal proteins. The
nutritional role of the amino acid L-valine is well established in the scientiﬁc literature. The product
L-valine is regarded as an efﬁcacious source of the essential amino acid L-valine for non-ruminant nutrition.
In ruminants, the amino acid valine has been implicated as being present at lower than optimum
levels in microbial protein leaving the rumen (O’Connor et al., 1993; Schwab et al., 2005). Thus, when
requirements for more limiting essential amino acids, usually L-methionine, L-lysine and L-histidine, have
been met, L-valine supplementation could be beneﬁcial. Free L-valine is rapidly degraded by ruminal
microbiota, with an estimated half-life in the rumen of 2.1 h (Chalupa, 1976). Broderick and Balthrop
(1979) found that 45% of free L-valine added to ruminal digesta in vitro remained after 3 h.
Accordingly, only small amounts of dietary L-valine provided to ruminants would be expected to reach
the abomasum intact and be absorbed. Therefore, measures, such as encapsulation, would ensure a
more efﬁcient delivery of L-valine beyond the rumen, and only limited nutritional beneﬁt may be
derived from dietary supplementation with the unprotected, free amino acid.
The additive L-valine produced by C. glutamicum CGMCC 11675 is regarded as an efﬁcacious source
of the amino acid L-valine for all animal species. For the supplemental L-valine to be as efﬁcacious in
ruminants as in non-ruminant species, protection against degradation in the rumen is required.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation41 and Good
Manufacturing Practice.
4. Conclusions
Owing to the uncertainties regarding the possible genetic modiﬁcation of the original production
strain, the FEEDAP Panel cannot conclude on the safety of the additive L-valine produced with
C. glutamicum CGMCC 11675 for the target species, the consumers, the users and the environment.
In the absence of data, the FEEDAP Panel cannot conclude on the potential of the L-valine
produced with C. glutamicum CGMCC 11675 to be toxic by inhalation, irritant to skin or eyes, or on its
potential to be a dermal sensitiser.
The FEEDAP Panel has concerns on the safety for the target animals of the simultaneous oral
administration of valine-containing additives via feed and water for drinking.
The product is considered an efﬁcacious source of the amino acid L-valine for all animal species.
The supplemental L-valine requires protection against rumen degradation in order to be as efﬁcacious
in ruminant as in non-ruminant species.
Documentation provided to EFSA
1) L-Valine produced by fermentation using C. glutamicum. August 2016. Submitted by Agri
Nutrition BV.
2) L-Valine produced by fermentation using C. glutamicum. Supplementary information. July
2017. Submitted by Agri Nutrition BV.
3) L-Valine produced by fermentation using C. glutamicum. Supplementary information. April
2018. Submitted by Agri Nutrition BV.
41 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for
feed hygiene. OJ L 35, 8.2.2005, p. 1.
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4) Evaluation report of the European Union Reference Laboratory for Feed Additives on the
Methods of Analysis for L-valine produced by Corynebacterium glutamicum CGMCC 11675.
5) Evaluation of the method of analysis to determine valine in the additive (batch to batch
variation) by the EURL (email).
6) Comments from Member States.
Chronology
Date Event
24/5/2016 Dossier received by EFSA
2/6/2016 Reception mandate from the European Commission
16/8/2016 Application validated by EFSA – Start of the scientiﬁc assessment
14/10/2016 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientiﬁc assessment suspended. Issues: Production process,
characterisation of the additive, characterisation of the production microorganism, stability and
capacity to distribute homogeneously in feed, safety for the user
16/11/2016 Comments received from Member States
16/11/2016 Reception of the Evaluation report of the European Union Reference Laboratory for Feed Additives
25/7/2017 Reception of supplementary information from the applicant – Scientiﬁc assessment re-started
25/10/2017 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientiﬁc assessment suspended Issues: Characterisation of the production
microorganism, characterisation of the additive
5/4/2018 Reception of supplementary information from the applicant – Scientiﬁc assessment re-started
3/9/2018 Request by email to the EURL to assess the method of analysis to determine valine in the additive
5/11/2018 EURL assessment of the method of analysis to determine valine in the additive received by email
23/1/2019 Opinion adopted by the FEEDAP Panel. End of the Scientiﬁc assessment
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AFC EFSA Panel on Food Additives, Flavourings, Processing Aids and Materials in contact with Food
ANI average nucleotide identity
BIOHAZ EFSA Panel on Biological Hazards
CAS Chemical Abstracts Service
CFU colony-forming unit
CGMCC Chinese General Microbiological Culture Collection Centre
DL-PCB dioxin-like polychlorinated biphenyls
EINECS European Inventory of Existing Commercial chemical Substances
EURL European Union Reference Laboratory
FCC Food Chemical Codex
FEEDAP EFSA Panel on Additives and Products or Substances used in Animal Feed
FLAVIS The EU Flavour Information System
FL-no FLAVIS number
IEC ion exchange chromatography
IUPAC International Union of Pure and Applied Chemistry
JECFA Joint FAO/WHO Expert Committee on Food Additives
PCDD polychlorinated dibenzodioxin
PCDF polychlorinated dibenzofuran
QPS qualiﬁed presumption of safety
RSDr relative standard deviation for repeatability
RSDR relative standard deviation for reproducibility
TEQ toxic equivalent
VKM Norwegian Scientiﬁc Committee for Food and Environment
WHO World Health Organization
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Method s of Analysis
for L-valine produced by Corynebacterium glutamicum CGMCC 11675
In the current application, authorisation is sought under Article 4(1) for L-valine produced by
Corynebacterium glutamicum CGMCC 11675, under the category/functional group 3(c) ‘nutritional
additives’/’amino acids, their salts and analogues’, according to Annex I of Regulation (EC) No 1831/2003.
Authorisation is sought for all animal species. L-Valine is already authorised as feed additive under
Commission Implementing Regulation (EU) 2015/1114 amending Regulation (EC) No 403/2009 and
Implementing Regulation (EU) No 848/2014 and (EU) 1236/2014.
For the quantiﬁcation of L-valine in feed additive, premixtures, feedingstuffs and water the Applicant
submitted the ring-trial validated Community method (Commission Regulation (EC) No 152/2009). The
method was further ring-trial validated by CEN resulting in EN ISO 13903:2005. The method is based
on ion exchange chromatography coupled with post-column derivatisation and photometric detection
(IEC-VIS). This method does not distinguish between the salts and the amino acid enantiomers and is
designed for feedingstuffs and premixtures. The following performance characteristics were reported
for the quantiﬁcation of total valine: a relative standard deviation for repeatability (RSDr) ranging from
1.7 to 3.8% and a relative standard deviation for reproducibility (RSDR) ranging from 8.8 to 16.1%.
In addition, the EURL identiﬁed the ‘L-arginine monograph’ of the Food Chemical Codex (FCC) for
the characterisation of the feed additive. Since the Applicant provided no experimental data to
determine valine in water’, the EURL is neither able to evaluate nor to recommend a method for ofﬁcial
control to determine valine in water.
Based on the performance characteristics available, the EURL recommends for ofﬁcial control the
Community method (equivalent to the EN ISO 13903:2005 method) based on IEC-VIS for the
quantiﬁcation of valine in the feed additive, premixtures and feedingstuffs together with the ‘L-valine
monograph’ of the FCC for the characterisation of the feed additive.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
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